iCubate

The company plans to launch a test for gram-negative bacteria next, and will work with developers and freelancers to develop additional assay content

Based on iCubate's Amplicon-Rescued Multiplex PCR technology, the iC-GPC assay is the first of the company's portfolio's to earn CE mark.

The iC-System is based on on iCubate's amplicon-rescued multiplex PCR technology, which detects multiple pathogens simultaneously.

Enrichment prior to amplification better enables studies of non-coding regions and epigenetic analyses, according to Ubiquity's founder.

Diatherix Laboratories, an independent CLIA-certified clinical laboratory providing multiplex molecular diagnostic services, said this week that it recently acquired from Qiagen the patent to target-enriched multiplexing, or TEM, PCR — a patent that Diatherix previously licensed

Samsung Electronics has been awarded US Patent No. 8,386,191, "Method for quantifying initial concentration of nucleic acid from real-time nucleic acid amplification data."
Kak Namkoong, Jin-tae Kim, Young-sun Lee, and Young-a Kim are named as inventors.

The grants, awarded through the Qualifying Therapeutic Discovery Project Program created by the Patient Protection and Affordable Care Act of 2010, were disclosed last week by the IRS.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.